Evidence map›Paper›PMID 42529516›Full record

ArticleEconomics letters2025

Medical Cannabis Dispensary Availability Improved Self-Reported Mental Health among Older Adults in New York.

Coleman Drake, Dylan Nagy, Matthew D Eisenberg, David Slusky

Abstract read
In one paragraph

Article in Economics letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Coleman DrakeUniversity of Pittsburgh School of Public Health.
Dylan NagyUniversity of Pittsburgh School of Public Health.
Matthew D EisenbergJohns Hopkins University Bloomberg School of Public Health.
David SluskyUniversity of Kansas Department of Economics.

Funding

Geographic Access to Medication Assisted Treatment for Medicaid Enrollees with Opioid Use DisorderK01DA051761 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DRAKE, COLEMAN · 2020 to 2023
$692k
NIDA NIH HHS K01 DA051761
6 · The paper itself

Abstract

Evidence regarding cannabis legalization's effects on mental health remains mixed, despite both rapid increases in cannabis use and an ongoing mental health crisis in the United States. We use granular geographic data to estimate medical cannabis dispensary availability's effects on self-reported mental health in New York state from 2011 through 2021 using a two-stage difference-in-differences approach to minimize bias introduced from the staggered opening of dispensaries. We find that medical cannabis availability reduced past-month self-reported poor mental health days by nearly 15%-3.77 percentage points-among adults 65 and above. Our findings also rule out that medical cannabis availability had negative effects on having past-month poor mental health days for the adult population overall. These results suggest medical cannabis, where it is geographically available, has positive mental health impacts for older populations.

Indexed as

agingCannabisdifference-in-differencesgeospatialH75I12I18I31K32K42mental healthsubstance use

Identifiers

PMID42529516
PMCPMC13417365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.